-+ 0.00%
-+ 0.00%
-+ 0.00%

Susquehanna Maintains Negative on RXO, Raises Price Target to $20

Benzinga·07/14/2026 12:59:27
Listen to the news
Susquehanna analyst Bascome Majors maintains RXO (NYSE:RXO) with a Negative and raises the price target from $18 to $20.